Highly cross-linked sodium hyaluronate 23 mg/ ml with 0.3% lidocaine hydrochloride
- UID
- MFG/MD/2023/000026_9e5123f2acfbb3f091d2e22562fd9866_0681550098a456b3c2c293e5238883b5
- Device class
- Class C
- Brand name
- Secondary Packing / Labeling / Stickering / Overprinting / Stamping
- License holder
- REENAV LOGISTICS PVT LTD
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- The device is indicated to correct moderate to severe nasolabial folds. It is indicated to be injected into the deep dermis or subcutis. The intended purpose of the device is to create volume in order to correct wrinkles and folds, and to correct moderate to severe nasolabial folds to treat signs of ageing
Highly cross-linked sodium hyaluronate 23 mg/ ml with 0.3% lidocaine hydrochloride is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2023/000026_9e5123f2acfbb3f091d2e22562fd9866_0681550098a456b3c2c293e5238883b5. This device is marketed under the brand name Secondary Packing / Labeling / Stickering / Overprinting / Stamping. The license holder is REENAV LOGISTICS PVT LTD, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.